| 000 | 01891 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250511222159.0 | ||
| 264 | 0 | _c19910522 | |
| 008 | 199105s 0 0 eng d | ||
| 022 | _a0934-9723 | ||
| 024 | 7 |
_a10.1007/BF01967377 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aArlet, G | |
| 245 | 0 | 0 |
_aOutbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cNov 1990 |
||
| 300 |
_a797-803 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aBacterial Typing Techniques |
| 650 | 0 | 4 |
_aCross Infection _xepidemiology |
| 650 | 0 | 4 | _aDisease Outbreaks |
| 650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIntensive Care Units |
| 650 | 0 | 4 | _aIsoelectric Focusing |
| 650 | 0 | 4 |
_aKlebsiella Infections _xepidemiology |
| 650 | 0 | 4 |
_aKlebsiella pneumoniae _xdrug effects |
| 650 | 0 | 4 |
_aParis _xepidemiology |
| 650 | 0 | 4 | _aR Factors |
| 650 | 0 | 4 |
_aRespiratory System _xmicrobiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSepsis _xmicrobiology |
| 650 | 0 | 4 |
_aSurgical Wound Infection _xmicrobiology |
| 650 | 0 | 4 |
_aUrinary Tract _xmicrobiology |
| 650 | 0 | 4 |
_abeta-Lactamases _xbiosynthesis |
| 650 | 0 | 4 | _abeta-Lactams |
| 700 | 1 | _aSanson-le Pors, M J | |
| 700 | 1 | _aRouveau, M | |
| 700 | 1 | _aFournier, G | |
| 700 | 1 | _aMarie, O | |
| 700 | 1 | _aSchlemmer, B | |
| 700 | 1 | _aPhilippon, A | |
| 773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 9 _gno. 11 _gp. 797-803 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01967377 _zAvailable from publisher's website |
| 999 |
_c2092379 _d2092379 |
||